74%
de inversores minoristas pierde dinero cuando opera con CFDs en este proveedor.
Las inversiones conllevan riesgos y no son adecuadas para todos los inversores. Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
74%
de inversores minoristas pierde dinero cuando opera con CFDs en este proveedor.
Debes considerar si comprendes cómo funcionan los CFDs y si puedes permitirte asumir el alto riesgo de perder tu dinero.
74%
de inversores minoristas pierde dinero cuando opera con CFDs en este proveedor.
Las inversiones conllevan riesgos y no son adecuadas para todos los inversores. Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
74%
de inversores minoristas pierde dinero cuando opera con CFDs en este proveedor.
Debes considerar si comprendes cómo funcionan los CFDs y si puedes permitirte asumir el alto riesgo de perder tu dinero.
Haemonetics Corp
Cerrado
SectorSanidad
59.94 0.54
Resumen
Variación precio
24h
Mínimo
59.36
Máximo
59.95
Ingresos | 6.1M 45M |
|---|---|
Ventas | 12M 339M |
P/B Media del Sector | 16.851 60.328 |
BPA | 0.95 |
Margen de beneficios | 13.199 |
Empleados | 3,023 |
EBITDA | 8.7M 95M |
Recomendaciones | Comprar |
|---|---|
Estimación a 12 Meses | +31.15% upside |
Próximas Ganancias | 7 may 2026 |
|---|
Capitalización Mercado | -306M 2.9B |
|---|---|
Apertura anterior | 59.4 |
Cierre anterior | 59.94 |
Puntuación técnica
By Trading Central
Confianza
Strong Bullish Evidence
Haemonetics Corp Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
Haemonetics Corp previsión
Precio Objetivo
By TipRanks
31.15% repunte
Estimación a 12 Meses
Media 78.6 USD 31.15%
Máximo 94 USD
Mínimo 64 USD
De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Haemonetics Corp Dist en los últimos 3 meses.
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de Haemonetics Corp
Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
